Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Il Farmaco; Edizione Scientifica
|
September 1, 1988
[Derivatives of pyrimidine 1,2-condensate. IV. Synthesis and pharmacological properties of the N,N-disubstituted 4-amino-2H-pyrido(1,2-a)pyrimidin- 2-ones and 2-amino-4H-pyrido(1,2-a)pyrmidin-4-ones]
M Di Braccio, G Roma, M Mazzei, et al.
Pharmacological Research
|
October 1, 1993
No-mimetic furoxans: arylsulphonylfuroxans and related compounds
R Ferioli, A Fazzini, G C Folco, et al.
Giornale Italiano Di Cardiologia
|
January 1, 1979
[Availability of volumertric indices detected from angiocardiography. A comparison between three different contrast media in anesthetized dogs (author's transl)]
M Di Donato, F Cucchini, G Baldi, et al.
La Clinica Terapeutica
|
May 15, 1985
[Experimental analysis of the beta-adrenergic stimulating activity of procaterol. Comparison with other beta-adrenergic agonists]
E Marmo, S Chieppa, F Rossi, et al.
Journal of Cardiovascular Pharmacology
|
April 29, 1998
Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion
R Latini, S Masson, G Jeremic, et al.
Journal of Cardiovascular Pharmacology
|
September 2, 1999
Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion
S Masson, M Masseroli, F Fiordaliso, et al.
Cardiovascular Drugs and Therapy
|
October 24, 2001
CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload
S Masson, S Chimenti, M Salio, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Il Farmaco; Edizione Scientifica
|
September 1, 1988
[Derivatives of pyrimidine 1,2-condensate. IV. Synthesis and pharmacological properties of the N,N-disubstituted 4-amino-2H-pyrido(1,2-a)pyrimidin- 2-ones and 2-amino-4H-pyrido(1,2-a)pyrmidin-4-ones]
M Di Braccio, G Roma, M Mazzei, et al.
Pharmacological Research
|
October 1, 1993
No-mimetic furoxans: arylsulphonylfuroxans and related compounds
R Ferioli, A Fazzini, G C Folco, et al.
Giornale Italiano Di Cardiologia
|
January 1, 1979
[Availability of volumertric indices detected from angiocardiography. A comparison between three different contrast media in anesthetized dogs (author's transl)]
M Di Donato, F Cucchini, G Baldi, et al.
La Clinica Terapeutica
|
May 15, 1985
[Experimental analysis of the beta-adrenergic stimulating activity of procaterol. Comparison with other beta-adrenergic agonists]
E Marmo, S Chieppa, F Rossi, et al.
Journal of Cardiovascular Pharmacology
|
April 29, 1998
Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion
R Latini, S Masson, G Jeremic, et al.
Journal of Cardiovascular Pharmacology
|
September 2, 1999
Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion
S Masson, M Masseroli, F Fiordaliso, et al.
Cardiovascular Drugs and Therapy
|
October 24, 2001
CHF-1024, a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload
S Masson, S Chimenti, M Salio, et al.
Page
of 7